tiprankstipranks
Trending News
More News >
Serina Therapeutics (SER)
:SER
US Market

Serina Therapeutics (SER) Financial Statements

Compare
196 Followers

Serina Therapeutics Financial Overview

Serina Therapeutics's market cap is currently $56.52M. The company's EPS TTM is $-0.49; its P/E ratio is ―; Serina Therapeutics is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 56.00K$ 142.00K$ 500.00K$ 3.04M$ 54.00K
Gross Profit$ -138.00K$ -29.00K$ 355.00K$ 2.89M$ -1.23M
Operating Income$ -17.05M$ -9.96M$ -2.27M$ -1.63M$ -10.41M
EBITDA$ -10.49M$ -9.78M$ -2.60M$ -1.59M$ -8.74M
Net Income$ -11.14M$ -14.80M$ -2.68M$ -1.26M$ -10.87M
Balance Sheet
Cash & Short-Term Investments$ 3.67M$ 345.00K$ 532.23K$ 1.31M$ 527.00K
Total Assets$ 6.72M$ 11.96M$ 858.04K$ 1.84M$ 3.92M
Total Debt$ 268.00K$ 4.37M$ 1.81M$ 398.17K$ 6.30M
Net Debt$ -3.40M$ 4.02M$ 1.28M$ 83.33K$ 5.77M
Total Liabilities$ 6.22M$ 6.61M$ 38.64M$ 36.95M$ 9.32M
Stockholders' Equity$ 641.00K$ 5.47M$ -37.78M$ -35.11M$ -5.12M
Cash Flow
Free Cash Flow$ -17.16M$ -7.80M$ -2.09M$ -2.36M$ -7.84M
Operating Cash Flow$ -17.14M$ -7.80M$ -2.08M$ -2.25M$ -7.82M
Investing Cash Flow$ -22.00K$ -10.00M$ 980.94K$ 823.32K$ -20.00K
Financing Cash Flow$ 13.21M$ 17.50M$ 1.31M$ 1.08M$ 5.96M
Currency in USD

Serina Therapeutics Earnings and Revenue History

Serina Therapeutics Debt to Assets

Serina Therapeutics Cash Flow

Serina Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis